Oncomyx Closes $50 Million Series B To Advance A Novel Immuno-Oncology Platform That Delivers Multiple Cancer-Killing Payloads
Amount Raised
$50 Million
Round Type
Series B
PhoenixBiotechnologyDescription
OncoMyx Therapeutics, a privately-held immuno-oncology platform company, today announced the closing of a $50 million Series B financing, co-led by Lumira Ventures and B Capital Group with participation from LYZZ Capital and all Series A investors: Boehringer Ingelheim Venture Fund, Delos Capital, Xeraya Capital, Korea Investment Partners, City Hill Ventures, and Madison Partners. In conjunction with the financing, Benjamin (Beni) Rovinski, Ph.D., Managing Director of Lumira Ventures and Widya Mulyasasmita, Ph.D., Senior Principal, Healthcare at B Capital Group will join the company’s Board of Directors. The proceeds of the financing will support the further development of OncoMyx’s pipeline of multi-armed myxoma immunotherapies for the treatment of solid tumors and hematological malignances and the advancement of the company’s lead candidate into clinical trials.
Quick answer
OncoMyx Therapeutics, Inc. raised $50 Million in a Series B round, dated December 8, 2021. OncoMyx Therapeutics, Inc. is based in Phoenix, Arizona, United States.
- How much did OncoMyx Therapeutics, Inc. raise?
- OncoMyx Therapeutics, Inc. raised $50 Million in a Series B round on December 8, 2021.
- What does OncoMyx Therapeutics, Inc. do?
- OncoMyx Therapeutics is advancing multi-armed, systemic immunotherapies with the potential to be broadly effective in treating solid tumors and heme cancers.
- Where is OncoMyx Therapeutics, Inc. based and how big is it?
- OncoMyx Therapeutics, Inc. is based in Phoenix, Arizona, United States.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as OncoMyx Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.
- GIOCAN Ltd raised an undisclosed amount on January 21, 2022.
- GIOHEALTH Ltd raised an undisclosed amount on January 21, 2022.
- GIOGI Ltd raised an undisclosed amount on January 21, 2022.
- GIODIA Ltd raised an undisclosed amount on January 21, 2022.
- GIO World Health Ltd raised an undisclosed amount on January 21, 2022.
- Grannus Therapeutics Inc. raised $950K (Seed) on January 21, 2022.
Who to call at OncoMyx Therapeutics, Inc., and when
A new round usually means OncoMyx Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day OncoMyx Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at OncoMyx Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at OncoMyx Therapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment OncoMyx Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansOncoMyx Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.